chr7-134158142-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144648.3(LRGUK):āc.778A>Gā(p.Ile260Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,612,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144648.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRGUK | NM_144648.3 | c.778A>G | p.Ile260Val | missense_variant | 6/20 | ENST00000285928.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRGUK | ENST00000285928.3 | c.778A>G | p.Ile260Val | missense_variant | 6/20 | 1 | NM_144648.3 | P2 | |
LRGUK | ENST00000695542.2 | c.778A>G | p.Ile260Val | missense_variant | 6/16 | A2 | |||
LRGUK | ENST00000645682.1 | c.778A>G | p.Ile260Val | missense_variant | 6/16 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250618Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135422
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1460300Hom.: 0 Cov.: 30 AF XY: 0.0000399 AC XY: 29AN XY: 726374
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.778A>G (p.I260V) alteration is located in exon 6 (coding exon 6) of the LRGUK gene. This alteration results from a A to G substitution at nucleotide position 778, causing the isoleucine (I) at amino acid position 260 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at